Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00356031
Title Bevacizumab and Radiation Therapy for Sarcomas
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

liposarcoma

leiomyosarcoma

fibrous histiocytoma

sarcoma

synovial sarcoma

fibrosarcoma

Therapies

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.